Psychosocial and Socioeconomic Factors in Children with Neurofibromatosis Type 1

Katalin Leppich; Joanna Schneider; Caroline Eismann; Monika Ryczek; Cornelia Potratz; Angela M. Kaindl

doi:10.1055/s-0041-1731393

Journal of Pediatric Neurology, Table of Contents

Journal of Pediatric Neurology 2022; 20(03): 188-193
DOI: 10.1055/s-0041-1731393

Original Article

Psychosocial and Socioeconomic Factors in Children with Neurofibromatosis Type 1

Katalin Leppich ‡^*

¹Center for Chronically Sick Children, Charité – Universitätsmedizin Berlin, Berlin, Germany

²Department of Pediatric Neurology, Charité – Universitätsmedizin Berlin, Berlin, Germany

,

Joanna Schneider‡^*

¹Center for Chronically Sick Children, Charité – Universitätsmedizin Berlin, Berlin, Germany

²Department of Pediatric Neurology, Charité – Universitätsmedizin Berlin, Berlin, Germany

,

Caroline Eismann

¹Center for Chronically Sick Children, Charité – Universitätsmedizin Berlin, Berlin, Germany

²Department of Pediatric Neurology, Charité – Universitätsmedizin Berlin, Berlin, Germany

,

Monika Ryczek

¹Center for Chronically Sick Children, Charité – Universitätsmedizin Berlin, Berlin, Germany

²Department of Pediatric Neurology, Charité – Universitätsmedizin Berlin, Berlin, Germany

,

Cornelia Potratz‡^*

¹Center for Chronically Sick Children, Charité – Universitätsmedizin Berlin, Berlin, Germany

²Department of Pediatric Neurology, Charité – Universitätsmedizin Berlin, Berlin, Germany

,

Angela M. Kaindl‡^*

¹Center for Chronically Sick Children, Charité – Universitätsmedizin Berlin, Berlin, Germany

²Department of Pediatric Neurology, Charité – Universitätsmedizin Berlin, Berlin, Germany

³Institute of Cell and Neurobiology, Charité – Universitätsmedizin Berlin, Berlin, Germany

› Author Affiliations

Abstract

The aim of this study is to analyze whether children with familial and sporadic neurofibromatosis type 1 (NF1) differ in psychosocial and socioeconomic aspects such as developmental delay as well as in comorbidities. Medical records of 250 children with NF1 at a median age of 10.6 years (range = 2–20 years at time of data collection) were retrospectively reviewed. Specifically, psychosocial and socioeconomic factors from 88 children with a family history for NF1 and 162 sporadic cases were compared. Comparing IQ, familial cases scored significantly lower than sporadic cases (89.8 vs. 96.5; p = 0.015). IQ scores of children with familial and sporadic NF1 differ depending on level of parental education (mean IQ for high education 101.3 [familial] and 102.8 [sporadic] vs. low education 87.5 [familial] and 90.4 [sporadic]; p < 0.001). No significant differences were found regarding the presence of developmental delay, learning disorders, autism spectrum disorder, or attention deficit hyperactivity disease. Children with inherited NF1 had a significantly lower IQ than sporadic cases. Children with familial NF1 more often had parents with a lower level of education, highlighting a possible impact of NF1 through generations. Also, the present study confirmed previous results in literature regarding high frequencies of learning disabilities, autism spectrum disease, and attention deficits in children with NF1.

Keywords

neurofibromatosis type 1 - neurofibromatosis - cognition - developmental delays - learning disorders

Full Text

References

References
1 Hirabaru K, Matsuo M. Neurological comorbidity in children with neurofibromatosis type 1. Pediatr Int (Roma) 2018; 60 (01) 70-75
2 Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL. Neurofibromatosis type 1 revisited. Pediatrics 2009; 123 (01) 124-133
3 Radtke HB, Sebold CD, Allison C, Haidle JL, Schneider G. Neurofibromatosis type 1 in genetic counseling practice: recommendations of the National Society of Genetic Counselors. J Genet Couns 2007; 16 (04) 387-407
4 Serra G, Antona V, Corsello G, Zara F, Piro E, Falsaperla R. NF1 microdeletion syndrome: case report of two new patients. Ital J Pediatr 2019; 45 (01) 138
5 Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 1988; 45 (05) 575-578
6 Hachon C, Iannuzzi S, Chaix Y. Behavioural and cognitive phenotypes in children with neurofibromatosis type 1 (NF1): the link with the neurobiological level. Brain Dev 2011; 33 (01) 52-61
7 Lehtonen A, Howie E, Trump D, Huson SM. Behaviour in children with neurofibromatosis type 1: cognition, executive function, attention, emotion, and social competence. Dev Med Child Neurol 2013; 55 (02) 111-125
8 Cutting LE, Levine TM. Cognitive profile of children with neurofibromatosis and reading disabilities. Child Neuropsychol 2010; 16 (05) 417-432
9 Sangster J, Shores EA, Watt S, North KN. The cognitive profile of preschool-aged children with neurofibromatosis type 1. Child Neuropsychol 2011; 17 (01) 1-16
10 Johnson NS, Saal HM, Lovell AM, Schorry EK. Social and emotional problems in children with neurofibromatosis type 1: evidence and proposed interventions. J Pediatr 1999; 134 (06) 767-772
11 Rietman AB, van der Vaart T, Plasschaert E. et al. Emotional and behavioral problems in children and adolescents with neurofibromatosis type 1. Am J Med Genet B Neuropsychiatr Genet 2018; 177 (03) 319-328
12 Lehtonen A, Garg S, Roberts SA. et al. Cognition in children with neurofibromatosis type 1: data from a population-based study. Dev Med Child Neurol 2015; 57 (07) 645-651
13 North K, Hyman S, Barton B. Cognitive deficits in neurofibromatosis 1. J Child Neurol 2002; 17 (08) 605-612 , discussion 627–629, 646–651
14 Prinzie P, Descheemaeker MJ, Vogels A. et al. Personality profiles of children and adolescents with neurofibromatosis type 1. Am J Med Genet A 2003; 118A (01) 1-7
15 Tröster H, Reineke D. Prävalenz von verhaltens- und entwicklungsauffälligkeiten im kindergartenalter: ergebnisse einer erhebung in kindergärten eines landkreises. [prevalence of behavior problems and developmental retardation in preschool age]. Kindheit und Entwicklung: Zeitschrift für Klinische Kinderpsychologie. 2007; 16 (03) 171-179
16 Valla L, Wentzel-Larsen T, Hofoss D, Slinning K. Prevalence of suspected developmental delays in early infancy: results from a regional population-based longitudinal study. BMC Pediatr 2015; 15: 215
17 Thompson HL. Evaluation of phonological processing skills of young children with neurofibromatosis type 1. Dev Med Child Neurol 2018; 60 (07) 642
18 Iannuzzi S, Albaret JM, Chignac C. et al. Motor impairment in children with neurofibromatosis type 1: effect of the comorbidity with language disorders. Brain Dev 2016; 38 (02) 181-187
19 Joy P, Roberts C, North K, de Silva M. Neuropsychological function and MRI abnormalities in neurofibromatosis type 1. Dev Med Child Neurol 1995; 37 (10) 906-914
20 Johnson B. Cognitive dysfunction, gait, and motor impairment in neurofibromatosis type 1. Dev Med Child Neurol 2014; 56 (05) 415
21 Descheemaeker MJ, Ghesquière P, Symons H, Fryns JP, Legius E. Behavioural, academic and neuropsychological profile of normally gifted neurofibromatosis type 1 children. J Intellect Disabil Res 2005; 49 (Pt 1): 33-46
22 Orraca-Castillo M, Estévez-Pérez N, Reigosa-Crespo V. Neurocognitive profiles of learning disabled children with neurofibromatosis type 1. Front Hum Neurosci 2014; 8: 386
23 Hyman SL, Arthur Shores E, North KN. Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder. Dev Med Child Neurol 2006; 48 (12) 973-977
24 Robert Koch-Institut, Ed. Bundeszentrale für gesundheitliche Aufklärung (Ed.). Erkennen – Bewerten – Handeln: Zur Gesundheit von Kindern und Jugendlichen in Deutschland. Accessed December 6, 2020 at: https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/Kiggs/Basiserh ebung/GPA_Daten/ADHS.pdf?blob=publicationFile
25 Hyman SL, Shores A, North KN. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology 2005; 65 (07) 1037-1044
26 Garg S, Green J, Leadbitter K. et al. Neurofibromatosis type 1 and autism spectrum disorder. Pediatrics 2013; 132 (06) e1642-e1648
27 Statistisches Bundesamt, (Destatis) (Ed.). Statistik der schwerbehinderten Menschen, Kurzbericht 2017. Accessed December 2, 2020 at: https://www.destatis.de/DE/Themen/Gesellschaft- Umwelt/Gesundheit/Behinderte-Menschen/Publikationen/Downloads- Behinderte-Menschen/sozial-schwerbehinderte-kb-5227101179004.pdf? blob=publicationFile
28 Rockmann U, Leerhoff H. Vorschulische Bildung in Berlin. Accessed November 22, 2020 at: https://www.bildungsbericht-berlin-brandenburg.de/pdfs2016/SP_VorschulischeBildung-000-000_DE_2016_BE.pdf
29 Krab LC, Aarsen FK, de Goede-Bolder A. et al. Impact of neurofibromatosis type 1 on school performance. J Child Neurol 2008; 23 (09) 1002-1010
30 Malecki A. Sonderpädagogischer Förderbedarf – eine differenzierte analyse. WISTA – Wirtschaft und Statistik. Accessed December 3, 2020 at: https://www.destatis.de/DE/Methoden/WISTA-Wirtschaft-und- Statistik/2014/10/sonderpaedagogischer-foerderbedarf-102014.html
31 Vogel AC, Gutmann DH, Morris SM. Neurodevelopmental disorders in children with neurofibromatosis type 1. Dev Med Child Neurol 2017; 59 (11) 1112-1116
32 Turkheimer E, Haley A, Waldron M, D'Onofrio B, Gottesman II. Socioeconomic status modifies heritability of IQ in young children. Psychol Sci 2003; 14 (06) 623-628
33 Feldmann R, Denecke J, Grenzebach M, Schuierer G, Weglage J. Neurofibromatosis type 1: motor and cognitive function and T2-weighted MRI hyperintensities. Neurology 2003; 61 (12) 1725-1728
34 Hou Y, Allen T, Wolters PL. et al. Predictors of cognitive development in children with neurofibromatosis type 1 and plexiform neurofibromas. Dev Med Child Neurol 2020; 62 (08) 977-984